PetIQ, Inc. (PETQ)

Market Cap	919.17M
Revenue (ttm)	1.13B
Net Income (ttm)	13.19M
Shares Out	29.67M
EPS (ttm)	0.45
PE Ratio	68.80
Forward PE	17.40
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	30.98
Day's Range	30.98 - 30.98
52-Week Range	15.09 - 31.06
Beta	1.74
Analysts	Strong Buy
Price Target	29.67 (-4.23%)
Earnings Date	Nov 5, 2024

About PETQ

PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats. It also provides OTC medications and supplies primarily within the...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Jul 21, 2017
• Employees: 1,933
• Stock Exchange: NASDAQ
• Ticker Symbol: PETQ
• Website: https://petiq.com

Analyst Forecast

According to 3 analysts, the average rating for PETQ stock is "Strong Buy." The 12-month stock price forecast is $29.67, which is a decrease of -4.23% from the latest price.

Price Target

$29.67

(-4.23% downside)

Analyst Consensus: Strong Buy